Princess Adila: Her Royal Highness, Her Human Mission
Inside the remarkable journey of Princess Adila bint Abdullah Al Saud. An exclusive interview for CancerWorld. When I entered the room, it felt as though I had stepped into a page from an Arabian fairytale. The room was quiet and…
Why Patient-Reported Outcomes are Rarely Used in Trials, and How We Change That
If drug developers design trials to measure how well their drug addresses the issues most important to the target patient community, we could expect to end up with better drugs.…
It’s no longer taboo to suggest that some metastatic breast cancers may be curable
It’s long been clear that, in most patients with metastatic HER-positive breast cancer, adding effective HER2 blockade to cytotoxics can result in very prolonged responses. Janet Fricker reports on the…
NEWS
How a Brain-Destroying Protein Became Cancer’s Ally: Alpha-Synuclein Emerges as a New Target in Melanoma
The alpha-synuclein, a protein long associated with Parkinson’s disease may hold the key to melanoma proliferation. The study, published in Science Advances, on 9 April, suggests that while excess alpha-synuclein results in cell death in neurons, conversely, it enables uncontrolled…
CONTENTS
ARTICLES
Suheir Rasul: Protecting Human Dignity
When Suheir Rasul talks about her journey, you don’t hear a linear career path—you hear a story of transformation, resilience, and service. Today, as Senior Vice President of ALSAC Global, the fundraising and awareness organization of St. Jude Children’s Research…
